NBPDP Formulary Update
|
|
|
- Ginger McGee
- 5 years ago
- Views:
Transcription
1 Bulletin # 830 April 4, 2012 NBPDP Formulary Update Please find attached lists of interchangeable product additions to the New Brunswick Prescription Drug Program Formulary and non-listed products subject to a Maximum Allowable Price (). Claims for products that are reimbursed at Actual Acquisition Cost () up to May 1, 2012 will be subject to a effective May 2, Please note: Hard copy versions of NBPDP Formulary Updates of interchangeable product additions will no longer be distributed. An electronic version is available on NBPDP webpage To unsubscribe from the NBPDP ed announcements, please send a message to info@nbpdp-pmonb.ca. The Updates are available on the NBPDP webpage:
2 Amlodipine Besylate Bésylate d'amlodipine Tab Orl 2.5mg Jamp-Amlodipine JPC AEFVW 5mg Jamp-Amlodipine JPC AEFVW 10mg Jamp-Amlodipine JPC AEFVW Bisoprolol Fumarate Fumarate de bisoprolol Tab Orl 5mg Ava-Bisoprolol AVA AEFVW 10mg Ava-Bisoprolol AVA AEFVW Clindamycin Hydrochloride Clindamycine (chlorhydrate de) Cap Orl 150mg Ava-Clindamycin AVA ABEFGVW 300mg Ava-Clindamycin AVA ABEFGVW Diltiazem Hydrochloride Diltiazem (chlorhydrate de) ERC Orl 120mg Co-Diltiazem T COB AEFVW Cap. L.P. 180mg Co-Diltiazem T COB AEFVW 240mg Co-Diltiazem T COB AEFVW 300mg Co-Diltiazem T COB AEFVW 360mg Co-Diltiazem T COB AEFVW Domperidone Maleate Dompéridone (maléate de) Tab Orl 10mg Ava-Domperidone AVA Entacapone Tab Orl 200mg Teva-Entacapone TEV Spec. Auth Famciclovir Tab Orl 125mg Ava-Famciclovir AVA 250mg Ava-Famciclovir AVA 500mg Ava-Famciclovir AVA Fenofibrate Fénofibrate Tab Orl 100mg Fenofibrate-S SAS 160mg Fenofibrate-S SAS Page 1 April/Avril 2012
3 Finasteride Finastéride Tab Orl 5mg Apo-Finasteride APX Spec.Auth. Furosemide Furosémide Tab Orl 20mg Ava-Furosemide AVA 40mg Ava-Furosemide AVA 80mg Ava-Furosemide AVA Gliclazide Tab Orl 80mg Ava-Gliclazide AVA ABEFGVW Hydromorphone Hydrochloride Hydromorphone (chlorhydrate d') Tab Orl 1mg Teva-Hydromorphone TEV 2mg Teva-Hydromorphone TEV 4mg Teva-Hydromorphone TEV 8mg Teva-Hydromorphone TEV Irbesartan Tab Orl 75mg Irbesartan SAS Mylan-Irbesartan MYL 150mg Irbesartan SAS Mylan-Irbesartan MYL 300mg Irbesartan SAS Mylan-Irbesartan MYL Irbesartan/Hydrochlorothiazide Tab Orl 150mg/12.5mg Irbesartan/HCTZ SAS 300mg/12.5mg Irbesartan/HCTZ SAS 300mg/25mg Irbesartan/HCTZ SAS Levofloxacin Lévofloxacine Tab Orl 250mg Ava-Levofloxacin AVA VW & Spec.Auth. 500mg Ava-Levofloxacin AVA VW & Spec.Auth. Lisinopril Tab Orl 5mg Jamp-Lisinopril JPC 10mg Jamp-Lisinopril JPC 20mg Jamp-Lisinopril JPC Page 2 April/Avril 2012
4 Losartan Potassium Losartan potassique Tab Orl 25mg Apo-Losartan APX Meloxicam Tab Orl 7.5mg Ava-Meloxicam AVA 15mg Ava-Meloxicam AVA Metformin Hydrochloride Metformine (chlorhydrate de) Tab Orl 500mg Ava-Metformin AVA 850mg Ava-Metformin AVA Metoprolol Tartrate Métoprolol (tartrate de) Tab Orl 25mg Jamp-Metoprolol-L JPC mg Jamp-Metoprolol-L JPC mg Jamp-Metoprolol-L JPC Mycophenolate Mofetil Mycophénolate Mofétil Tab Orl 500mg Co-Mycophenolate COB R Nabilone Cap Orl 0.5mg pms-nabilone PMS Caps Ran-Nabilone RAN Spec. Auth mg pms-nabilone PMS Ran-Nabilone RAN Spec. Auth Olanzapine Tab Orl 2.5mg Olanzapine SAS W & Spec. Auth. 5mg Olanzapine SAS W & Spec. Auth. 7.5mg Olanzapine SAS W & Spec. Auth. 10mg Olanzapine SAS W & Spec. Auth. 15mg Olanzapine SAS W & Spec. Auth. Omeprazole Oméprazole SRT Orl 20mg Ran-Omeprazole RAN ABEFGVW L.L. Oxycodone Hydrochloride/Acetaminophen Oxycodone (chlorhydrate d')/acétaminophène Tab Orl 5mg/325mg Oxycodone/Acet SAS Page 3 April/Avril 2012
5 Pantoprazole Sodium Pantoprazole sodique ECT Orl 40mg Pantoprazole SAS Spec. Auth. Ent. Rabeprazole Sodium Rabéprazole sodique ECT Orl 10mg Apo-Rabeprazole APX ABEFGVW Ent. 20mg Apo-Rabeprazole APX ABEFGVW Ramipril Cap Orl 2.5mg Ramipril SAS 5mg Ramipril SAS 10mg Ramipril SAS Rosuvastatin Calcium Rosuvastatin calcique Tab Orl 10mg Apo-Rosuvastatin APX Co-Rosuvastatin COB Mylan-Rosuvastatin MYL pms-rosuvastatin PMS Ran-Rosuvastatin RAN Sandoz Rosuvastatin SDZ Teva-Rosuvastatin TEV AEFVW mg Apo-Rosuvastatin APX Co-Rosuvastatin COB Mylan-Rosuvastatin MYL pms-rosuvastatin PMS Ran-Rosuvastatin RAN Sandoz Rosuvastatin SDZ Teva-Rosuvastatin TEV AEFVW mg Apo-Rosuvastatin APX Co-Rosuvastatin COB Mylan-Rosuvastatin MYL pms-rosuvastatin PMS Ran-Rosuvastatin RAN Sandoz Rosuvastatin SDZ Teva-Rosuvastatin TEV AEFVW Sertraline Hydrochloride Sertraline (chlorhydrate de) Cap Orl 25mg Ran-Sertraline RAN 50mg Ran-Sertraline RAN 100mg Ran-Sertraline RAN Page 4 April/Avril 2012
6 Simvastatin Simvastatine Tab Orl 5mg Mar-Simvastatin MAR 10mg Mar-Simvastatin MAR 20mg Mar-Simvastatin MAR 40mg Mar-Simvastatin MAR 80mg Mar-Simvastatin MAR Sotalol Hydrochloride Sotalol (chlorhydrate de) Tab Orl 80mg Ava-Sotalol AVA 160mg Ava-Sotalol AVA Sumatriptan Tab Orl 50mg Ava-Sumatriptan AVA Spec. Auth. 100mg Ava-Sumatriptan AVA Spec. Auth. Telmisartan/Hydrochlorothiazide Tab Orl 80mg/12.5mg Teva-Telmisartan HCTZ TEV 80mg/25mg Teva-Telmisartan HCTZ TEV Valsartan Tab Orl 80mg Ava-Valsartan AVA 160mg Ava-Valsartan AVA 320mg Ava-Valsartan AVA Valsartan/Hydrochlorothiazide Tab Orl 80mg/12.5mg Ava-Valsartan HCT AVA 160mg/12.5mg Ava-Valsartan HCT AVA 160mg/25mg Ava-Valsartan HCT AVA 320mg/12.5mg Ava-Valsartan HCT AVA 320mg/25mg Ava-Valsartan HCT AVA Venlafaxine Hydrochloride Venlafaxine (chlorhydrate de) SRC Orl 37.5mg GD-Venlafaxine XR GMD Cap.L.L. Ran-Venlafaxine XR RAN 75mg GD-Venlafaxine XR GMD Ran-Venlafaxine XR RAN 150mg GD-Venlafaxine XR GMD Ran-Venlafaxine XR RAN Page 5 April/Avril 2012
7 Zopiclone Tab Orl 5mg Ava-Zopiclone AVA AEFVW 7.5mg Ava-Zopiclone AVA AEFVW NON-LISTED PRODUCTS SUBJECT TO / PRODUITS NE FIGURANT PAS SUR LA LISTE ASSUJETIS AUX PAM Atomoxetine Hydrochloride Atomoxétine (chlorhydrate d') Cap Orl 18mg Mylan-Atomoxetine MYL 25mg Mylan-Atomoxetine MYL 40mg Mylan-Atomoxetine MYL 60mg Mylan-Atomoxetine MYL Esomeprazole Magnesium Trihydrate Esoméprazole magnésien trihydraté ERT Orl 20mg Apo-Esomeprazole APX L.P. Rosuvastatin Calcium Rosuvastatin calcique Tab Orl 5mg Apo-Rosuvastatin APX Co-Rosuvastatin COB Mylan-Rosuvastatin MYL pms-rosuvastatin PMS Ran-Rosuvastatin RAN Sandoz Rosuvastatin SDZ Teva-Rosuvastatin TEV Valacyclovir Tab Orl 1000mg pms-valacyclovir PMS Valsartan Tab Orl 40mg Ava-Valsartan AVA Page 6 April/Avril 2012
Product Selection Committee / Comité de sélection des produits
New Brunswick Pharmaceutical Society and New Brunswick Department of Health Product Selection Committee / Comité de sélection des produits L Ordre des pharmaciens P.O. Box / C.P. 5100, Fredericton NB E3B
NB Drug Plans Formulary Update
Bulletin #915 October 30, 2015 NB Drug Formulary Update Please find attached a list of generic drug product updates for the New Brunswick Drug Formulary. Generic drug product additions New generic products
NBPDP Formulary Update
Bulletin # 880 January 28, 2014 NBPDP Formulary Update Please find attached a list of interchangeable product additions to the New Brunswick Prescription Drug Program Formulary. Existing interchangeable
NBPDP Formulary Update
Bulletin # 853 January 31, 2013 NBPDP Formulary Update Please find attached lists of interchangeable product additions to the New Brunswick Prescription Drug Program Formulary and non-listed products subject
Product Selection Committee / Comité de sélection des produits
New Brunswick Pharmaceutical Society and New Brunswick Department of Health Product Selection Committee / Comité de sélection des produits L Ordre des pharmaciens P.O. Box / C.P. 5100, Fredericton NB E3B
NB Drug Plans Formulary Update
Bulletin #960 October 31, 2017 NB Drug Formulary Update Please find attached a list of generic drug product updates for the New Brunswick Drug Formulary. Generic drug product additions New generic products
A BULLETIN FOR PHARMACY SERVICE PROVIDERS FROM ALBERTA BLUE CROSS. Pan-Canadian Select Molecule Price Initiative for Generic Drugs
Pharmacy Benefact A BULLETIN FOR PHARMACY SERVICE PROVIDERS FROM ALBERTA BLUE CROSS Number 723 February 2018 Pan-Canadian Select Molecule Price Initiative for Generic Drugs Alberta Drug Benefit List prices
NB Drug Plans Formulary Update
Bulletin #973 April 30, 2018 NB Drug Plans Formulary Update Generic drug product updates included in this bulletin: Generic drug product additions - New generic products will be reimbursed up to the category
New Interchangeable Products Approved and Benefit Status Within the Nova Scotia Pharmacare Programs March 2016
PAGE 1 OF 6 New Interchangeable Products Approved and Benefit Status Within the Nova Scotia Pharmacare Programs March New Categories A Maximum Reimbursable Price (MRP) or Pharmacare Reimbursement Price
BULLETIN # 101. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 18, 2018
BULLETIN # 101 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on October 18, 2018 The amended Manitoba Specified Drug Regulation and Drug Interchangeability
BULLETIN # 74. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 17, 2013
BULLETIN # 74 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on October 17, 2013 The amended Manitoba Specified Drug Regulation and Drug Interchangeability
NB Drug Plans Formulary Update
Bulletin #984 October 31, 2018 NB Drug Formulary Update Drug product updates included in this bulletin: Drug product additions - New generic products will be reimbursed up to the category Maximum Allowable
BULLETIN # 70. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on January 21, 2013
BULLETIN # 70 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on January 21, 2013 The amended Manitoba Specified Drug Regulation and Drug Interchangeability
BULLETIN # 73. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on July 17, 2013
BULLETIN # 73 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on July 17, 2013 The amended Manitoba Specified Drug Regulation and Drug Interchangeability
NB Drug Plans Formulary Update
Bulletin #942 January 27, 2017 NB Drug Plans Formulary Update Please find attached a list of generic drug product updates for the New Brunswick Drug Plans Formulary. Generic drug product additions New
ANNOUNCEMENT. Dear Valued Customer:
ANNOUNCEMENT Dear Valued Customer: This is to notify you that Ranbaxy Canada s products will not be currently distributed to you through Kohl and Frisch; however Kohl and Frisch will continue their support
ASEBP and ARTA TARP Drugs and Reference Price by Categories
ASEBP Pantoprazole Sodium 40 mg (generic) $0.2016 ASEBP Dexlansoprazole 30 mg Dexlansoprazole 60 mg Esomeprazole 10 mg Esomeprazole 20 mg Esomeprazole 40 mg Lansoprazole 15 mg Lansoprazole 30 mg Omeprazole
BULLETIN # 78. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on July 17, 2014
BULLETIN # 78 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on July 17, 2014 The amended Manitoba Specified Drug Regulation and Drug Interchangeability
UPDATE AF Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective March 26, 2012 SUMMARY OF CHANGES
UPDATE AF Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective March 26, 2012 SUMMARY OF CHANGES TABLE OF CONTENTS Page New Multi-Source Drug(s) 2 Off Formulary Interchangeable Product(s)
BULLETIN # 84. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 22, 2015
BULLETIN # 84 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on October 22, 2015 The amended Manitoba Specified Drug Regulation and Drug Interchangeability
Updates to the Alberta Drug Benefit List. Effective September 1, 2018
Updates to the Alberta Drug Benefit List Effective September 1, 2018 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number: (780)
Table 1: Price increases for Brand Name Drugs with Generic Equivalents
Table 1: Price increases for Brand Name Drugs with Generic Equivalents Brand Name Medication and Dose Total % Change Since 10/2012 ACTOS 15 MG TABLET 6.36 11.03 73.39% ACTOS 30 MG TABLET 9.7 16.80 73.23%
Ontario Drug Benefit Formulary/Comparative Drug Index
Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 43 Summary of Changes June 2018 Effective June 29, 2018 Drug Programs Policy and Strategy Branch Ontario
BULLETIN # 72. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on April 18, 2013
BULLETIN # 72 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on April 18, 2013 The amended Manitoba Specified Drug Regulation and Drug Interchangeability
2018 Step Therapy Criteria
2018 Step Therapy Criteria ANGIOTENSIN RECEPTOR BLOCKERS... 2 ANTIDEPRESSANTS... 3 ANTIDEPRESSANTS, MISCELLANEOUS... 4 ANTIDEPRESSANTS, OTHER... 5 ANTIDIABETIC AGENTS... 6 ANTIGOUT AGENTS... 7 ANTIHYPERTENSIVE
Ontario Drug Benefit Formulary/Comparative Drug Index
Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 43 Summary of Changes August 2018 Effective August 30, 2018 Drug Programs Policy and Strategy Branch
CLAIM SUBMISSION QUANTITIES
Bulletin #704 January 11, 2008 CLAIM SUBMISSION QUANTITIES Please find attached a list of the units of measure to be used when determining the quantity for NBPDP claim submissions. Using the correct units
BULLETIN # 79. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 16, 2014
BULLETIN # 79 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on October 16, 2014 The amended Manitoba Specified Drug Regulation and Drug Interchangeability
Nova Scotia Pharmacare Programs Interchangeable Product Updates November 13, 2018 New Categories
PAGE 1 OF 7 Nova Scotia Pharmacare Programs Interchangeable Product Updates November 13, New Categories A Maximum Reimbursable Price (MRP) or Pharmacare Reimbursement Price (PRP) has been established for
Ontario Drug Benefit Formulary/ Comparative Drug Index
Ontario Drug Benefit Formulary/ Comparative Drug Index Edition 42 Summary of Changes March 2014 Effective March 27, 2014 Ministry of Health and Long-Term Care Table of Contents Additions to Formulary...
UPDATE AX Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective August 29, 2013 SUMMARY OF CHANGES
UPDATE AX Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective August 29, 2013 SUMMARY OF CHANGES TABLE OF CONTENTS Page New Single Source Drug(s) 2 New Multi-Source Drug(s) 4 Off Formulary
Updates to the Alberta Drug Benefit List. Effective November 1, 2018
Updates to the Alberta Drug Benefit List Effective November 1, 2018 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number: (780)
Updates to the Alberta Health and Wellness Drug Benefit List
Updates to the Alberta Health and Wellness Drug Benefit List Effective May 1, 2012 UPDATES TO THE ALBERTA HEALTH AND WELLNESS DRUG BENEFIT LIST Inquiries should be directed to: Pharmacy Services Alberta
BULLETIN # 90. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on January 25, 2017
BULLETIN # 90 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on January 25, 2017 The amended Manitoba Specified Drug Regulation and Drug Interchangeability
Alaska Medicaid 90 Day** Generic Prescription Medication List
1 ACYCLOVIR 200 MG CAPSULE BUPROPION HCL 150 MG TAB ER 24H ACYCLOVIR 200 MG/5ML BUPROPION HCL 150 MG TABLET ER ACYCLOVIR 400 MG TABLET BUPROPION HCL 150 MG TABLET ER ACYCLOVIR 800 MG TABLET BUPROPION HCL
Manager, PEI Drug Programs Date : December 7, 2009 Tel / Tél : (902) Fax / Téléc : (902)
DRAFT To / Destinataire : All Retail Pharmacists and Staff From / Expéditeur : Faye Campbell Manager, PEI Drug Programs Date : December 7, 2009 Tel / Tél : (902) 368-6338 Fax / Téléc : (902) 368-4905 Subject
DT Description Price Category Price change Percentage BNF 1.2 Mebeverine 135mg tablets (100) 759 M %
June 2016 On 13th May, the DH announced that there would be reductions to Category M prices from June until September. http://psnc.org.uk/our-news/contractor-notice-category-m-price-reduction/ This has
Updates to the Alberta Drug Benefit List. Effective February 1, 2018
Updates to the Alberta Drug Benefit List Effective February 1, 2018 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number: (780)
Ontario Drug Benefit Formulary/Comparative Drug Index
Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 43 Summary of Changes December 2018 Effective December 21, 2018 Drug Programs Policy and Strategy Branch
Archived Content. This content was archived on June 24, 2013.
This content was archived on June 24, 2013. Archived Content Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after
Riesbeck's Pharmacy Reward Club Generic Medication List October 2017
Allergy, Cold & Flu Antibiotic Treatments Arthritis & Pain Benzonatate 100mg cap 14 42 Diphenhydramine HCl Cap 50 MG 30 90 Diphenhydramine HCl Inj 50MG/ML 1 3 Diphenhydramine HCl Liquid 12.5 MG/5ML 720ml
Ontario Drug Benefit Formulary/Comparative Drug Index
Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes - October 2015 Effective October 29, 2015 Drug Program Services Branch/Ontario
NB Drug Plans Formulary Update
Bulletin #920 January 29, 2016 NB Drug Plans Formulary Update Please find attached a list of generic drug product updates for the New Brunswick Drug Plans Formulary. Generic drug product additions New
DT Description Price Category Price change
Tariff T Watch October 2014 Readers are no doubt aware of this quarter's bad news for primary care prescribing allocations: NHS England has d the remuneration mechanism for community pharmacies gaining
BULLETIN # 80. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on January 19, 2015
BULLETIN # 80 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on January 19, 2015 The amended Manitoba Specified Drug Regulation and Drug Interchangeability
Published by the Pharmaceutical Services Division to provide information for British Columbia s health care providers
Published by the Pharmaceutical Services Division to provide information for British Columbia s health care providers QuickLinks Keeping the Lines Clear... 1 Newsletter Notification Service... 1 Special
Ontario Drug Benefit Formulary/Comparative Drug Index
Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes - August 2015 Effective August 26, 2015 Ministry of Health and Long-Term Care Table of Contents New Single Source Products...
Riesbeck's Pharmacy Reward Club Generic Medication List February 2018 $4 30 Day Supply
Allergy, Cold & Flu Antibiotic Treatments Arthritis & Pain Benzonatate 100mg cap 14 42 Diphenhydramine HCl Cap 50 MG 30 90 Diphenhydramine HCl Inj 50MG/ML 1 3 Diphenhydramine HCl Liquid 12.5 MG/5ML 720ml
SASKATCHEWAN FORMULARY BULLETIN Update to the 60th Edition of the Saskatchewan Formulary
Saskatchewan Ministry of Health November 1, 2010 Drug Plan and Extended Benefits Branch Bulletin #126 ISSN 1923-077X SASKATCHEWAN FORMULARY BULLETIN Update to the 60th Edition of the Saskatchewan Formulary
Riesbeck's Pharmacy Reward Club Generic Medication List September 2017
Drug Category Allergy, Cold & Flu Antibiotic Treatments Arthritis & Pain Riesbeck's Benzonatate 100mg cap 14 42 Diphenhydramine HCl Cap 50 MG 30 90 Diphenhydramine HCl Liquid 12.5 MG/5ML 720ml 2160ml Hydroxyzine
Updates to the Alberta Drug Benefit List. Effective July 1, 2018
Updates to the Alberta Drug Benefit List Effective July 1, 2018 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number: (780) 498-8370
While there is around a 3% increase shown in costs for Category M lines, I think this is due to the inclusion of more lines in Category M.
April 2018 The usual quarterly of Category M prices Another set of similar comments as I made in January: significant increases in many lines which have been subject to price concessions but even more
UPDATE AU Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective May 31, 2013 SUMMARY OF CHANGES
UPDATE AU Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective May 31, 2013 SUMMARY OF CHANGES TABLE OF CONTENTS Page New Multi-Source Drug(s) 2 Off Formulary Interchangeable Product(s)
Ontario Drug Benefit Formulary/Comparative Drug Index
Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 43 Summary of Changes March 2019 Effective March 28, 2019 Drug Programs Policy and Strategy Branch Drugs
ATYPICAL ANTIPSYCHOTICS
Step Therapy CareOregon 2018 Last Updated: 07/27/2018 ATYPICAL ANTIPSYCHOTICS Fanapt Fanapt Titration Pack Paliperidone Er Vraylar The following criteria applies to members who newly start on the drug:
PRODUCT LIST June 2018
ACEBUTOLOL HCl (34381-68-5) -, JP 16 AMANTADINE HCl (665-66-7) Antiviral - Antiparkinsonian, JP 16 AMANTADINE SULPHATE (31377-23-8) Antiviral - Antiparkinsonian DAC 2011 AMLODIPINE BESILATE (111470-99-6)
Ontario Drug Benefit Formulary/Comparative Drug Index
Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes - January 2015 Effective January 28, 2015 Ministry of Health and Long-Term Care Table of Contents New Multi-Source Products...
Ontario Drug Benefit Formulary/Comparative Drug Index
Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes - November 2014 Effective November 27, 2014 Ministry of Health and Long-Term Care Table of Contents New Single Source
UPDATE AJ Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective July 27, 2012 SUMMARY OF CHANGES
UPDATE AJ Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective July 27, 2012 SUMMARY OF CHANGES TABLE OF CONTENTS Page New Single Source Drug(s) 2 New Multi-Source Drug(s) 5 Off Formulary
UPDATE AB Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective October 25, 2011 SUMMARY OF CHANGES
UPDATE AB Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective October 25, 2011 SUMMARY OF CHANGES TABLE OF CONTENTS Page New Single Source Drug(s) 2 New Multi-Source Drug(s) 5 Off Formulary
SASKATCHEWAN FORMULARY COMMITTEE BULLETIN TO THE 58th EDITION OF THE SASKATCHEWAN FORMULARY
Saskatchewan Ministry of Health Drug Plan and Extended Benefits Branch July 2008 Bulletin #115 ISSN 0708-3246 SASKATCHEWAN FORMULARY COMMITTEE BULLETIN TO THE 58th EDITION OF THE SASKATCHEWAN FORMULARY
Innovative Products Available. OTC Products Available
Innovative Products Benfotiamine film-coated tablets 150 mg Cholecalciferol film-coated tablets 22400 I.U. Diltiazem rectal ointment 2% Agents for Treatment of Hemorrhoids and Fissures Blood and Blood
Ontario Drug Benefit Formulary/Comparative Drug Index
Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes - February 2015 Effective February 26, 2015 Ministry of Health and Long-Term Care Table of Contents New Multi-Source
Ontario Drug Benefit Formulary/Comparative Drug Index
Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes - July 2014 Effective July 30, 2014 Ministry of Health and Long-Term Care Table of Contents New Single Source Products...
DRUG CLASSIFICATION. Prevention of Cardiovascular Disease
Generic Preventive Care/ Safe Harbor Drug Program List Preventive care/safe harbor drugs are drugs that can help keep you from developing a health condition or related complications of a health condition.
DT Description Price Category Price change Percentage BNF 1.2 Mebeverine 135mg tablets (100) 702 M %
December 16 No Category M changes so the reductions imposed in May which were only supposed to last until September continue As in November, most changes are Category A lines with a few Category C. Significant
Summary of Changes to the Alberta Health and Wellness Drug Benefit List
Summary of Changes to the Alberta Health and Wellness Drug Benefit List Effective April 1, 2010 ABC 40211/81160 (R2010/04) Table of Contents Special Authorization...1 New Drug Product(s) Available by Special
Ontario Drug Benefit Formulary/Comparative Drug Index
Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes July 2016 Effective July 28, 2016 Drug Programs Policy and Strategy Branch Ontario
SASKATCHEWAN FORMULARY COMMITTEE BULLETIN FOR THE UPDATE TO THE 56th EDITION OF THE SASKATCHEWAN FORMULARY
Saskatchewan Health Drug Plan and Extended Benefits Branch January 2007 Bulletin #109 ISSN 0708-3246 SASKATCHEWAN FORMULARY COMMITTEE BULLETIN FOR THE UPDATE TO THE 56th EDITION OF THE SASKATCHEWAN FORMULARY
Ontario Drug Benefit Formulary/ Comparative Drug Index
Ontario Drug Benefit Formulary/ Comparative Drug Index Edition 42 Summary of Changes December 2013 Effective January 03, 2014 Ministry of Health and Long-Term Care Table of Contents Additions to Formulary...
UPDATE B Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective October 01, 2008 SUMMARY OF CHANGES
UPDATE B Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective October 01, 2008 SUMMARY OF CHANGES TABLE OF CONTENTS Page New Multi-Source Drug(s) 2 Manufacturer Requested Discontinued
ACEBUTOLOL HCL 100MG TABLET GENERIC BETA BLOCKERS ALISKIREN 150MG TABLET RASILAZ RENIN INHIBITOR
S/N ME OF MEDICATIONS BRANDED/GENERIC DRUG CLASS * UNIT PRICE RANGE (SGD$) 1 ACEBUTOLOL HCL 100MG CAPSULE SECTRAL BETA BLOCKERS 0.50 2 ACEBUTOLOL HCL 100MG TABLET GENERIC BETA BLOCKERS 0.33 3 ALISKIREN
QTY LIMIT COPAY (30 DAY/90 DAY) BENIGN PROSTATIC HYPERPLASIA FINASTERIDE $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8
2019 LiveWELL Health Plan PREVENTIVE DRUG LIST - GENERIC Names ( Copay) - ALPHABETICAL by DRUG CATEGORY You should always check with your prescriber and/or pharmacist to determine if these alternatives
DT Description Price Category Price change Percentage
June 2017 A slight inflationary pressure in most CCGs from mainly Category A increases. Significant price increases: Most of low concern although those involving the less frequently used tamoxifen strengths
Ontario Drug Benefit Formulary/Comparative Drug Index
Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes September 2017 Effective September 28, 2017 Drug Programs Policy and Strategy Branch
Ontario Drug Benefit Formulary/Comparative Drug Index
Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes June 2017 Effective June 29, 2017 Drug Programs Policy and Strategy Branch Ontario
BULLETIN # 102. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on January 24, 2019
BULLETIN # 102 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on January 24, 2019 The amended Manitoba Specified Drug Regulation and Drug Interchangeability
COMMERCIAL APIs. S. No Molecule Name Therapeutic Category USDMF EDMF CEP IH
1 Abacavir Sulphate Antiretroviral - * - 2 Abiraterone Acetate Oncology - - - 3 Albendazole Anti-infective - - - 4 Albuterol Sulphate Respiratory - - 5 Alendronate Sodium Trihydrate Metabolic Disorder
Ontario Drug Benefit Formulary/Comparative Drug Index
Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes July 2017 Effective July 31, 2017 Drug Programs Policy and Strategy Branch Ontario
NBPDP FORMULARY UPDATE
Bulletin #864 June 20, 2013 NBPDP FORMULARY UPDATE This update to the New Brunswick Prescription Drug Program (NBPDP) Formulary is effective June 20, 2013. Included in this bulletin: Regular Benefit Additions
Therapeutic Substitution Service - Proton Pump Inhibitors (PPIs)
FEBRUARY 2014 Nova Scotia Pharmacare Programs Updates Therapeutic Substitution Service - Proton Pump Inhibitors (PPIs) Prescription Adaptation Minimum Days' Supply Nova Scotia Formulary Updates Pan-Canadian
Ambetter 90-Day-Supply Maintenance Drug List
Ambetter 90-Day-Supply Maintenance Drug List What is the Ambetter 90-Day-Supply Maintenance Drug List? Ambetter 90-Day-Supply Maintenance Drug List is a list of maintenance medications that are available
Generic Preventive Care/ Safe Harbor Drug Program List
Preventive care/safe harbor drugs are drugs that can help keep you from developing a health condition or related complications of a health condition. The Generic Preventive Care/Safe Harbor Drug Program
Ontario Drug Benefit Formulary/Comparative Drug Index
Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes - December 2014 Effective December 18, 2014 Ministry of Health and Long-Term Care Table of Contents New Multi-Source
SASKATCHEWAN FORMULARY BULLETIN. Update to the 60th Edition of the Saskatchewan Formulary
Saskatchewan Ministry of Health July 1, 2010 Drug Plan and Extended Benefits Branch Bulletin #124 ISSN 1923-077X SASKATCHEWAN FORMULARY BULLETIN Update to the 60th Edition of the Saskatchewan Formulary
Glossary of Medications
CLPNA Medications Administration Module Glossary of Medications Acetaminophen. Acetaminophen is a non-opioid analgesic used to manage mild pain and fever. Acetylsalicylic acid. Acetylsalicylic acid is
UPDATE AA Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective September 15, 2011 SUMMARY OF CHANGES
UPDATE AA Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective September 15, 2011 SUMMARY OF CHANGES TABLE OF CONTENTS Page New Single Source Drug(s) 2 New Multi-Source Drug(s) 3 Off
20:00. Blood Formulation, Coagulation and Thrombosis. 20:00 Blood Formulation, Coagulation and Thrombosis
Blood Formulation, Coagulation and Thrombosis Blood Formulation, Coagulation and Thrombosis 20:04.04 ANTIANEMIA DRUGS (IRON PREPARATIONS) IRON DEXTRAN COMPLEX 50 MG / ML INJECTION 00002205963 DEXIRON LPI
Archived Content. This content was archived on June 24, 2013.
This content was archived on June 24, 2013. Archived Content Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after
Ontario Drug Benefit Formulary/Comparative Drug Index
Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 43 Summary of Changes April 2018 Effective April 30, 2018 Drug Programs Policy and Strategy Branch Ontario
Pharmacy Savings Program
Pharmacy Savings Program SELECT GENERICS DRUG LIST The Pharmacy Savings Program provides you with savings on select generic medications included on this list. The prices for these select generic medications
THERAPEUTIC AREA NAME STRENGTH DOSAGE FORM
Value Based Tier Drugs are selected for the management of Asthma, Diabetes, Hypertension and Hyperlipidemia. These drugs are covered at no charge or at a reduced cost share. Medications are under continual
BENEFIT CHANGES TO NBPDP
Bulletin #743 February 9, 2009 BENEFIT CHANGES TO NBPDP This update to the New Brunswick Prescription Drug Program (NBPDP) Formulary is effective February 9, 2009. Included in this bulletin: Regular Benefit
Non-Insured Health Benefits
Winter/Spring 2014 Non-Insured Health Benefits First Nations and Inuit Health Branch Updates to the Drug Benefit List The Non-Insured Health Benefits (NIHB) Program provides supplementary health benefits,
Guide to the Modernized Reference Drug Program
Guide to the Modernized Reference Drug Program For prescribers and pharmacists Medical Beneficiary and Pharmaceutical Services Division June 1, 2016 Contents 1 Introduction 1 2 About this Guide 2 3 About
Product Name Strength Dosage Form Therapeutic Area Dossier Status. Aceclofenac 100mg Film coated Tablets Analgesia-inflammation Approved
Product Name Strength Dosage Form Therapeutic Area Dossier Status Aceclofenac 100mg Film coated Tablets Analgesia-inflammation Approved Alendronate Sodium 10/70mg Tablets Osteoporosis Approved Anastrozole
New Exception Status Benefits
JULY 2012 Nova Scotia Formulary Updates New Exception Status Benefits Criteria Update: Xarelto Criteria Update: Sutent New Diabetic Products PRP Non-Insured Products Pharmacare Reimbursement Changes to
Ontario Drug Benefit Formulary/Comparative Drug Index
Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes October 2017 Effective October 30, 2017 Drug Programs Policy and Strategy Branch
Ontario Drug Benefit Formulary/Comparative Drug Index
Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 43 Summary of Changes February 2019 Effective February 28, 2019 Drug Programs Policy and Strategy Branch
BULLETIN # 98. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on April 19, 2018
BULLETIN # 98 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on April 19, 2018 The amended Manitoba Specified Drug Regulation and Drug Interchangeability